NCT00111969View on ClinicalTrials.gov

ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

2,016

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

November 30, 2005

Conditions
Heart Failure, Congestive
Interventions
DEVICE

Celacade™ system

Sponsors

Lead Sponsor

Vasogen
All Listed Sponsors
lead

Vasogen

INDUSTRY

NCT00111969 - ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy | Biotech Hunter | Biotech Hunter